The aromatic polyketide tetracenomycin X (TcmX) was recently found to be a potent inhibitor of protein synthesis; its binding site is located in a unique locus within the tunnel of the large ribosomal subunit. The distinct mode of action makes this relatively narrow class of aromatic polyketides promising for drug development in the quest to prevent the spread of drug-resistant pathogens. We isolated two novel tetracenomycin congeners – 6-hydroxytetracenomycin X (6-OH-TcmX) and O4-Me-Tcm C (TcmX isomer). Spectral properties of the compounds were studied. 6-OH-TcmX exhibited lower antimicrobial and cytotoxic activity, whereas TcmX isomer was found to be completely inactive. Interestigly, in vitro protein synthesis inhibition ability of TcmX and 6-OH-TcmX were found to be comparable, suggesting a significant influence of 6-hydroxylation on the tetracenomycin X cell penetration ability. Complete absence of both antimicrobial activity and in vitro protein synthesis inhibition ability of TcmX isomer corroborates crucial role of 4-OH group in ribosome binding. This work was supported in part by Ministry of Science and Higher Education of the Russian Federation (Agreement No 075–15-2021-1085). V.A. Alferova was supported by a RF President’s Scholarship (project SP-4094.2022.4).
Previous Article in event
Next Article in event
Natural extract-loaded wet-spun fibers encapsulated within a hydrogel matrix for potential uses in the treatment of skin infectionsNext Article in session
Structure-activity relationship for natural tetracenomycin X congeners
Published: 15 June 2022 by MDPI in The 2nd International Electronic Conference on Antibiotics—Drugs for Superbugs: Antibiotic Discovery, Modes of Action And Mechanisms of Resistance session Antimicrobial Discovery, Development & Optimization
Keywords: Aromatic polyketides; protein synthesis inhibitors; structure-activity relationship; antibiotics